Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

An Examination of Device Types and Features Used by Adult Electronic Nicotine Delivery System (ENDS) Users in the PATH Study, 2015-2016.

Coleman B, Chang JT, Rostron BL, Johnson SE, Das B, Del Valle-Pinero AY.

Int J Environ Res Public Health. 2019 Jul 2;16(13). pii: E2329. doi: 10.3390/ijerph16132329.

2.

Associations of Cigarettes Smoked Per Day with Biomarkers of Exposure Among US Adult Cigarette Smokers in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Rostron BL, Corey CG, Chang JT, van Bemmel DM, Miller ME, Chang CM.

Cancer Epidemiol Biomarkers Prev. 2019 Jun 25. pii: cebp.0013.2019. doi: 10.1158/1055-9965.EPI-19-0013. [Epub ahead of print]

PMID:
31239264
3.

Waterpipe or Hookah-Related Poisoning Events Among U.S. Adolescents and Young Adults.

Rostron BL, Wang B, Liu ST.

J Adolesc Health. 2019 Jun;64(6):800-803. doi: 10.1016/j.jadohealth.2018.12.021. Epub 2019 Mar 7.

PMID:
30852103
4.

Cigar smoking prevalence and morbidity among US adults, 2000-2015.

Rostron BL, Corey CG, Gindi RM.

Prev Med Rep. 2019 Feb 11;14:100821. doi: 10.1016/j.pmedr.2019.100821. eCollection 2019 Jun.

5.

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Chang CM, Rostron BL, Chang JT, Corey CG, Kimmel HL, Sosnoff CS, Goniewicz ML, Edwards KC, Hatsukami DK, Wang Y, Del Valle-Pinero AY, Yang M, Travers MJ, Arnstein S, Taylor K, Conway K, Ambrose BK, Borek N, Hyland A, Wang L, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953. doi: 10.1158/1055-9965.EPI-18-0539. Epub 2019 Feb 7.

PMID:
30733305
6.

Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis.

Rostron BL, Chang JT, Anic GM, Tanwar M, Chang CM, Corey CG.

Open Heart. 2018 Oct 8;5(2):e000846. doi: 10.1136/openhrt-2018-000846. eCollection 2018.

7.

Tobacco-related Poison Events Involving Young Children in the US, 2001-2016.

Wang B, Rostron B.

Tob Regul Sci. 2017 Oct;3(4):525-535. doi: 10.18001/TRS.3.4.12.

8.

Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015).

Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, Choi K, Anic G, Goniewicz ML, Cummings KM, Kasza KA, Silveira ML, Delnevo C, Niaura R, Abrams DB, Kimmel HL, Borek N, Compton WM, Hyland A.

Tob Control. 2019 Jan;28(1):50-59. doi: 10.1136/tobaccocontrol-2017-054174. Epub 2018 Apr 25.

9.

Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States.

Apelberg BJ, Feirman SP, Salazar E, Corey CG, Ambrose BK, Paredes A, Richman E, Verzi SJ, Vugrin ED, Brodsky NS, Rostron BL.

N Engl J Med. 2018 May 3;378(18):1725-1733. doi: 10.1056/NEJMsr1714617. Epub 2018 Mar 15. No abstract available.

10.

Electronic nicotine delivery system (ENDS) battery-related burns presenting to US emergency departments, 2016.

Corey CG, Chang JT, Rostron BL.

Inj Epidemiol. 2018 Mar 5;5(1):4. doi: 10.1186/s40621-018-0135-1.

11.

Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population.

Christensen CH, Rostron B, Cosgrove C, Altekruse SF, Hartman AM, Gibson JT, Apelberg B, Inoue-Choi M, Freedman ND.

JAMA Intern Med. 2018 Apr 1;178(4):469-476. doi: 10.1001/jamainternmed.2017.8625.

12.

E-cigarette and Smokeless Tobacco Use and Switching Among Smokers: Findings From the National Adult Tobacco Survey.

Anic GM, Holder-Hayes E, Ambrose BK, Rostron BL, Coleman B, Jamal A, Apelberg BJ.

Am J Prev Med. 2018 Apr;54(4):539-551. doi: 10.1016/j.amepre.2017.12.010. Epub 2018 Feb 21.

PMID:
29429605
13.

US Adult Cigar Smoking Patterns, Purchasing Behaviors, and Reasons for Use According to Cigar Type: Findings From the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Corey CG, Holder-Hayes E, Nguyen AB, Delnevo CD, Rostron BL, Bansal-Travers M, Kimmel HL, Koblitz A, Lambert E, Pearson JL, Sharma E, Tworek C, Hyland AJ, Conway KP, Ambrose BK, Borek N.

Nicotine Tob Res. 2018 Nov 15;20(12):1457-1466. doi: 10.1093/ntr/ntx209.

PMID:
29059423
14.

Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014.

Cheng YC, Rostron BL, Day HR, Stanton CA, Hull LC, Persoskie A, Travers MJ, Taylor K, Conway KP, Ambrose BK, Borek N.

Am J Public Health. 2017 Sep;107(9):1508-1514. doi: 10.2105/AJPH.2017.303921. Epub 2017 Jul 20.

15.

Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Coleman BN, Rostron B, Johnson SE, Ambrose BK, Pearson J, Stanton CA, Wang B, Delnevo C, Bansal-Travers M, Kimmel HL, Goniewicz ML, Niaura R, Abrams D, Conway KP, Borek N, Compton WM, Hyland A.

Tob Control. 2017 Dec;26(e2):e117-e126. doi: 10.1136/tobaccocontrol-2016-053462. Epub 2017 Jun 17.

PMID:
28624763
16.

The thalamus as a relay station and gatekeeper: relevance to brain disorders.

Moustafa AA, McMullan RD, Rostron B, Hewedi DH, Haladjian HH.

Rev Neurosci. 2017 Feb 1;28(2):203-218. doi: 10.1515/revneuro-2016-0067. Review.

PMID:
28085677
17.

Dependence symptoms and cessation intentions among US adult daily cigarette, cigar, and e-cigarette users, 2012-2013.

Rostron BL, Schroeder MJ, Ambrose BK.

BMC Public Health. 2016 Aug 18;16(1):814. doi: 10.1186/s12889-016-3510-2.

18.

Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.

Rostron BL, Chang CM, van Bemmel DM, Xia Y, Blount BC.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1829-37. doi: 10.1158/1055-9965.EPI-15-0376.

19.

Flavored Tobacco Product Use Among US Youth Aged 12-17 Years, 2013-2014.

Ambrose BK, Day HR, Rostron B, Conway KP, Borek N, Hyland A, Villanti AC.

JAMA. 2015 Nov 3;314(17):1871-3. doi: 10.1001/jama.2015.13802. No abstract available.

20.

Systematic review of cigar smoking and all cause and smoking related mortality.

Chang CM, Corey CG, Rostron BL, Apelberg BJ.

BMC Public Health. 2015 Apr 24;15:390. doi: 10.1186/s12889-015-1617-5. Review.

21.

A systematic review of transitions between cigarette and smokeless tobacco product use in the United States.

Tam J, Day HR, Rostron BL, Apelberg BJ.

BMC Public Health. 2015 Mar 18;15:258. doi: 10.1186/s12889-015-1594-8. Review.

22.

Modeling the potential effects of new tobacco products and policies: a dynamic population model for multiple product use and harm.

Vugrin ED, Rostron BL, Verzi SJ, Brodsky NS, Brown TJ, Choiniere CJ, Coleman BN, Paredes A, Apelberg BJ.

PLoS One. 2015 Mar 27;10(3):e0121008. doi: 10.1371/journal.pone.0121008. eCollection 2015.

23.

Biomarkers of exposure among U.S. cigar smokers: an analysis of 1999-2012 National Health and Nutrition Examination Survey (NHANES) data.

Chen J, Kettermann A, Rostron BL, Day HR.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2906-15. doi: 10.1158/1055-9965.EPI-14-0849. Epub 2014 Nov 7.

24.

Estimation of cigarette smoking-attributable morbidity in the United States.

Rostron BL, Chang CM, Pechacek TF.

JAMA Intern Med. 2014 Dec;174(12):1922-8. doi: 10.1001/jamainternmed.2014.5219.

PMID:
25317719
25.

Perceptions of the relative harm of cigarettes and e-cigarettes among U.S. youth.

Ambrose BK, Rostron BL, Johnson SE, Portnoy DB, Apelberg BJ, Kaufman AR, Choiniere CJ.

Am J Prev Med. 2014 Aug;47(2 Suppl 1):S53-60. doi: 10.1016/j.amepre.2014.04.016.

26.

Mortality and economic costs from regular cigar use in the United States, 2010.

Nonnemaker J, Rostron B, Hall P, MacMonegle A, Apelberg B.

Am J Public Health. 2014 Sep;104(9):e86-91. doi: 10.2105/AJPH.2014.301991. Epub 2014 Jul 17.

27.

Menthol cigarette use and stroke risk among US smokers: a critical reappraisal.

Rostron B.

JAMA Intern Med. 2014 May;174(5):808-9. doi: 10.1001/jamainternmed.2013.9600. No abstract available.

PMID:
24614962
28.

Mortality risks associated with environmental tobacco smoke exposure in the United States.

Rostron B.

Nicotine Tob Res. 2013 Oct;15(10):1722-8. doi: 10.1093/ntr/ntt051. Epub 2013 Jul 13.

PMID:
23852001
29.

21st-century hazards of smoking and benefits of cessation in the United States.

Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R.

N Engl J Med. 2013 Jan 24;368(4):341-50. doi: 10.1056/NEJMsa1211128.

30.

Methodology, menthol, and mortality.

Rostron B.

Nicotine Tob Res. 2013 Feb;15(2):619. doi: 10.1093/ntr/nts179. Epub 2013 Jan 4. No abstract available.

PMID:
23291639
31.

NNAL exposure by race and menthol cigarette use among U.S. smokers.

Rostron B.

Nicotine Tob Res. 2013 May;15(5):950-6. doi: 10.1093/ntr/nts223. Epub 2012 Oct 22.

PMID:
23089487
32.

Response to "menthol cigarettes and lung cancer mortality".

Rostron B.

Nicotine Tob Res. 2012 Oct;14(10):1248. No abstract available.

PMID:
23012335
33.

Smoking-attributable mortality by cause in the United States: revising the CDC's data and estimates.

Rostron B.

Nicotine Tob Res. 2013 Jan;15(1):238-46. doi: 10.1093/ntr/nts120. Epub 2012 May 16.

PMID:
22592446
34.

Lung cancer mortality risk for U.S. menthol cigarette smokers.

Rostron B.

Nicotine Tob Res. 2012 Oct;14(10):1140-4. Epub 2012 Mar 1.

PMID:
22387991
35.

Alcohol consumption and mortality risks in the USA.

Rostron B.

Alcohol Alcohol. 2012 May-Jun;47(3):334-9. doi: 10.1093/alcalc/agr171. Epub 2012 Jan 25.

PMID:
22278318
36.

Estimating the effect of smoking on slowdowns in mortality declines in developed countries.

Rostron BL, Wilmoth JR.

Demography. 2011 May;48(2):461-79. doi: 10.1007/s13524-011-0020-9.

PMID:
21519979
37.

Smoking-attributable mortality in the United States.

Rostron B.

Epidemiology. 2011 May;22(3):350-5. doi: 10.1097/EDE.0b013e3182126729.

PMID:
21378573
38.

United States life tables, 2005.

Arias E, Rostron BL, Tejada-Vera B.

Natl Vital Stat Rep. 2010 Mar 3;58(10):1-132.

39.

Education reporting and classification on death certificates in the United States.

Rostron BL, Boies JL, Arias E.

Vital Health Stat 2. 2010 May;(151):1-21.

Supplemental Content

Loading ...
Support Center